Antibodies against epidermal growth factor receptor (EGFR) and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9226964
SERIAL NO

14147331

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Anti-EGFR antibodies, therapeutic compositions comprising combinations of anti-EGFR antibodies, as well as methods for using such antibodies and compositions to treat EGFR-related disorders (e.g., cancers), are disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ADIMAB LLC7 LUCENT DRIVE LEBANON NH 03766

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bukhalid, Raghida Melrose, US 13 89
Feldhaus, Michael Grantham, US 46 636
Kearns, Jeffrey David Arlington, US 15 78
King, Anne Cambridge, US 10 71
Kohli, Neeraj Brighton, US 35 225
Krauland, Eric Lebanon, US 24 118
Lugovskoy, Alexey A Woburn, US 34 237
Nielsen, Ulrik Quincy, US 46 603

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 5, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00